We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
N4 Pharma Plc | LSE:N4P | London | Ordinary Share | GB00BYW8QM32 | ORD 0.4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.80 | 0.75 | 0.85 | 0.80 | 0.80 | 0.80 | 24,007 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Drug & Proprietary Stores | 0 | -1.03M | -0.0057 | -1.40 | 1.45M |
Date | Subject | Author | Discuss |
---|---|---|---|
22/2/2018 07:32 | remarkomsoc, you mean the difference between N4P's Nuvec and the current lipid / nanoparticle drug method? N4P's CEO said this last November (link below) and an additional study highlighting the differences is awaited as well:- For Nuvec :- Non in-vito toxicity (tested in animals & humans), no unwanted inflammatory responses, provides high DNA loading capacity, protection of DNA from enzymes, delivery of large nucleic acids in-vivo studies. : not so for any of that list current lipid / nanoparticle system Pharmas are currently using lipid / nanoparticles but “many problems” Nuvec :- Uniquely designed to work with the shape & structure of DNA / RNA : not so for current lipid / nanoparticle system Nuvec :- Can get a lot more DNA / RNA loaded. A really high level of DNA loaded and bound on its way to the cell. An incredibly high amount. Nuvec :- “Don't get much falling off with around 95% reaching it's target - with lipid / nanoparticle system as little as 10% can reach the target. Falling off with lipid / nanoparticle system ends up with unwanted Immunotherapy effect. “You want the DNA to do its thing in the cell you don't want it floating around the rest of the body ending up in the wrong place.” Nuvec: “clever design” Nuvec :- “Not difficult to make. Not a hugely expensive manufacturing process. Very,very well placed when we start taking it to market” Nuvec :- “Can probably deliver 4 or 5 DNA / RNA strings at the same time. Another key benefit in the delivery.” | nick2412 | |
21/2/2018 22:49 | These are the organizations represented at Thursdays meeting. | hughwilson | |
21/2/2018 22:30 | Thursday it is then: | hughwilson | |
21/2/2018 22:06 | Staggering potential here, i dont have as many as some, but there is no way under the sun i will be letting these go at this price. | escapetohome | |
21/2/2018 21:43 | Take care mate. | cryptotrade | |
21/2/2018 21:13 | To be upfront, I bought in mid 28, and 32, But researched the company in advance. Lots of folk were ranting about the increase, potential but I held off, missed my entry . However My moniker doesn't contradict how I invest. But I wish you the best, and he'll yeah this will be a rollercoaster, and hope your earn. Gla. | l0ngterm | |
21/2/2018 21:06 | Long-term, no worries. Best of luck. Happy for you all who have stock at 5/10p. Great buy. | cryptotrade | |
21/2/2018 21:05 | You suck it Vols. | cryptotrade | |
21/2/2018 21:05 | No offence meant, I do admire your style, and honesty. We are invested here because we see a rise, you might wish to play the surf in between. But now we are clear, we will understand each other. | l0ngterm | |
21/2/2018 21:03 | I like plates with food, you have a point demonstrating a lazy approach. Still, I'll watch the plate next time. 25p it is. | cryptotrade | |
21/2/2018 21:02 | Why bother reading when I can challenge you, and you put it on a plate. | l0ngterm | |
21/2/2018 21:00 | No problems. It was clear at the start. It's obvious if you read it all. Questioning is one thing, not reading the original posts is another. Onwards and upwards. | cryptotrade | |
21/2/2018 20:56 | that's better crypto, you have clarified your position. You wish to trade brilliant. You have a technical analysis. As for me questioning, it's a public board if you don't want challenged, or to share your thoughts , then don't post publicly. We have now move forward, you want in and wish to take up a position. Thanks for confirming. | l0ngterm | |
21/2/2018 20:35 | Sorry just to clarify: you basically state don't trust what people say on boards ( get it )Then follow up with 25p (without a technically analysis, supporting info etc) Don't get it, why bother?But your are following the share. So basically, all I can can deduce is that you want to buy (otherwise why follow, comment). But you want to buy at 0.25p!Or did I miss something? | l0ngterm | |
21/2/2018 20:14 | Sorry can you please clarify your statements. As there are sweeping generalisations across the comments made? Even more so, one comment one cancels the other out! | l0ngterm | |
21/2/2018 13:29 | Parob, only time seperates us from three figures, and not a lot of it either. | hughwilson | |
21/2/2018 10:55 | Lucky I didn't take the advice and buy at 35p. I'd be 20% down. You never know it may retest 25p or maybe, just maybe stock is needed so a decent shake is coming. nothing wrong with that. | cryptotrade | |
21/2/2018 10:52 | Courtesy of Nick posted over on lse:More importantly for buy and hold shareholders are these questions (listed below) rather than whether 30 .12321 is resistance or 29.455737373 is support :- 1) Have N4P in the form of Nuvec got a vastly superior DNA drug delivery system for use in multi billion $ markets that is going to be taken up by the likes of Medimmune / AZ and become an industry standard? 2) Have N4P got a superior patented form of off patent Viagra with excellent existing safety data and good near-term (in pharma timescales) prospects to be licensed out with a downpayment milestone that exceeds the current market cap and bring in 10% plus royalties for its share of a multi-billion market? 3) Can N4P fast track to FDA approval? 4) Have N4P got a conveyor belt of similar prospects including some tackling bigger markets? 5) Is all of this incredibly low cost, reasonably near-term and lower risk given the existing safety data for the reformulations? If the answer is yes to these questions (and I believe all suggest a resounding yes) then, as some have already said, N4P will be valued in pounds not pence. It's my belief that this is one of those stocks where those who just hold their stock rather than trade for a penny here and there will benefit most. N4P do also put out intra-day announcements when appropriate. I'm keenly awaiting newsflow on Nuvec differentiation, Slidanifil results and potential news additional collaborations for Nuvec. | parob | |
21/2/2018 10:14 | £10 today | cryptotrade | |
21/2/2018 09:41 | Eddie "The emphasis on this trip is to form collaborations" Collaborations lead to deals. | hughwilson | |
21/2/2018 09:33 | Hugh I think you will find that it's you that's wrong old bean Take a look below to jog your poor memory hughwilson 9 Feb '18 - 15:27 - 1964 of 2404 The emphasis on this trip is to form collaborations and sign deals. I am EXPECTING very positive news from the trip. Eddie_Yates 9 Feb '18 - 16:17 - 1965 of 2404 Edit Do you mean hoping for Hugh? hughwilson 9 Feb '18 - 16:25 - 1966 of 2404 No, I mean EXPECTING. | eddie_yates | |
21/2/2018 09:15 | Eddie, you are wrong as per usual. What I actually said was that logic would say that we would have news. I have always said that deals were possible but that collaborations were more likely. | hughwilson |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions